The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 13, 2016
Filed:
Mar. 13, 2014
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Yan Shi, Flourtown, PA (US);
Peter T. W. Cheng, Princeton, NJ (US);
Ying Wang, Belle Mead, NJ (US);
Shung C. Wu, Princeton, NJ (US);
Hao Zhang, Belle Mead, NJ (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/04 (2006.01); C07D 231/12 (2006.01); C07D 239/38 (2006.01); C07D 271/06 (2006.01); C07D 307/79 (2006.01); C07D 333/16 (2006.01); C07D 333/28 (2006.01); C07D 333/56 (2006.01); A61K 45/06 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/397 (2006.01); A61K 31/415 (2006.01); A61K 31/4245 (2006.01); A61K 31/505 (2006.01); C07C 59/13 (2006.01); C07C 69/675 (2006.01); C07C 69/708 (2006.01); C07C 69/732 (2006.01); C07C 69/734 (2006.01); C07C 69/736 (2006.01); C07C 69/757 (2006.01); C07C 69/76 (2006.01); C07C 43/192 (2006.01); C07C 43/196 (2006.01); C07C 47/277 (2006.01); C07C 59/72 (2006.01); C07C 62/34 (2006.01); C07C 311/51 (2006.01); C07C 235/26 (2006.01); C07C 237/22 (2006.01); A61K 31/192 (2006.01); C07C 59/215 (2006.01); C07C 205/34 (2006.01); C07C 323/19 (2006.01);
U.S. Cl.
CPC ...
C07C 59/13 (2013.01); A61K 31/192 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/397 (2013.01); A61K 31/415 (2013.01); A61K 31/4245 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); C07C 43/192 (2013.01); C07C 43/196 (2013.01); C07C 47/277 (2013.01); C07C 59/215 (2013.01); C07C 59/72 (2013.01); C07C 62/34 (2013.01); C07C 69/675 (2013.01); C07C 69/708 (2013.01); C07C 69/732 (2013.01); C07C 69/734 (2013.01); C07C 69/736 (2013.01); C07C 69/757 (2013.01); C07C 69/76 (2013.01); C07C 205/34 (2013.01); C07C 235/26 (2013.01); C07C 237/22 (2013.01); C07C 311/51 (2013.01); C07C 323/19 (2013.01); C07D 205/04 (2013.01); C07D 231/12 (2013.01); C07D 239/38 (2013.01); C07D 271/06 (2013.01); C07D 307/79 (2013.01); C07D 333/16 (2013.01); C07D 333/28 (2013.01); C07D 333/56 (2013.01); C07C 2101/02 (2013.01); C07C 2102/08 (2013.01); C07C 2102/42 (2013.01);
Abstract
The present invention provides compounds of Formula (I): (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.